H. B. Fuller Company (NYSE:FUL – Get Free Report) Director Charles Lauber purchased 2,005 shares of the business’s stock in a transaction dated Tuesday, September 29th. The stock was bought at an average price of $49.87 per share, with a total value of $99,989.35. Following the acquisition, the director directly owned 3,356 shares in the company, valued at approximately $167,363.72. This represents a 148.41% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
H. B. Fuller Stock Up 0.1%
FUL stock opened at $50.28 on Friday. The company has a current ratio of 1.82, a quick ratio of 1.10 and a debt-to-equity ratio of 0.95. The company’s 50-day moving average price is $55.13 and its 200 day moving average price is $58.13. H. B. Fuller Company has a 52 week low of $46.70 and a 52 week high of $68.63. The company has a market cap of $2.71 billion, a P/E ratio of 14.00, a P/E/G ratio of 0.62 and a beta of 0.99.
H. B. Fuller (NYSE:FUL – Get Free Report) last issued its earnings results on Thursday, September 24th. The specialty chemicals company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.05. H. B. Fuller had a net margin of 5.56% and a return on equity of 12.65%. The company had revenue of $938.17 million during the quarter, compared to analysts’ expectations of $945.59 million. During the same period last year, the company posted $1.26 earnings per share. The firm’s quarterly revenue was up 5.2% compared to the same quarter last year. On average, research analysts expect that H. B. Fuller Company will post 4.88 earnings per share for the current fiscal year.
H. B. Fuller Announces Dividend
More H. B. Fuller News
Here are the key news stories impacting H. B. Fuller this week:
- Positive Sentiment: Multiple directors bought approximately $620,000 of FUL shares. Recent purchases by Celine Martin, Michael Happe, Srilata Zaheer, Charles Lauber, Teresa Rasmussen, Daniel Florness and Thomas Handley were generally made near $49-$50 per share. The purchases significantly increased several directors’ holdings and may signal confidence that the shares are undervalued. H. B. Fuller director insider purchases
- Positive Sentiment: FUL was highlighted as a top-ranked value stock by Zacks. The company trades at roughly 14 times earnings, with a price-to-earnings-growth ratio near 0.61. The value designation may attract investors seeking relatively inexpensive specialty-chemical companies. Zacks value-stock analysis
- Positive Sentiment: H. B. Fuller maintained its quarterly dividend. The company declared a $0.245-per-share payment for October 29, equivalent to $0.98 annually and a yield of approximately 1.9%. The payout ratio is about 27%, leaving room for continued investment and debt management.
- Neutral Sentiment: Recent earnings provided modest fundamental support. Quarterly EPS of $1.52 exceeded the $1.47 consensus, while revenue increased 5.2% year over year to about $938 million. However, sales were slightly below expectations, tempering the earnings beat.
- Negative Sentiment: Analyst target reductions reflect a more cautious outlook. Deutsche Bank issued a pessimistic forecast, while JPMorgan, Baird and Citigroup also lowered targets, although most analysts still rate FUL Buy or Overweight. The consensus target remains about $64.62, above recent trading levels. The shares also remain below their 50-day and 200-day moving averages, indicating persistent market skepticism. Deutsche Bank forecast for H. B. Fuller
Wall Street Analyst Weigh In
FUL has been the topic of a number of research analyst reports. Raymond James Financial set a $67.00 target price on H. B. Fuller in a research report on Friday, June 26th. Weiss Ratings downgraded H. B. Fuller from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, September 14th. The Goldman Sachs Group set a $67.00 price objective on shares of H. B. Fuller in a research report on Friday, June 26th. Wall Street Zen cut shares of H. B. Fuller from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 25th. Finally, JPMorgan Chase & Co. dropped their target price on shares of H. B. Fuller from $67.00 to $66.00 and set an “overweight” rating for the company in a report on Monday, September 28th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $64.62.
View Our Latest Research Report on FUL
Institutional Investors Weigh In On H. B. Fuller
A number of hedge funds and other institutional investors have recently modified their holdings of FUL. Dimensional Fund Advisors LP lifted its stake in shares of H. B. Fuller by 5.4% during the first quarter. Dimensional Fund Advisors LP now owns 2,608,006 shares of the specialty chemicals company’s stock valued at $160,854,000 after buying an additional 132,558 shares during the period. Norges Bank purchased a new stake in H. B. Fuller in the 4th quarter worth approximately $44,203,000. Royal Bank of Canada grew its stake in H. B. Fuller by 2,694.7% in the 1st quarter. Royal Bank of Canada now owns 675,765 shares of the specialty chemicals company’s stock worth $41,681,000 after acquiring an additional 651,585 shares during the period. Kennedy Capital Management LLC raised its holdings in H. B. Fuller by 43.4% in the 4th quarter. Kennedy Capital Management LLC now owns 630,194 shares of the specialty chemicals company’s stock valued at $37,471,000 after acquiring an additional 190,750 shares during the last quarter. Finally, Bank of America Corp DE raised its holdings in H. B. Fuller by 36.3% in the 1st quarter. Bank of America Corp DE now owns 513,163 shares of the specialty chemicals company’s stock valued at $31,652,000 after acquiring an additional 136,666 shares during the last quarter. 95.93% of the stock is currently owned by hedge funds and other institutional investors.
H. B. Fuller Company Profile
H.B. Fuller Company is a global manufacturer of adhesives, sealants and specialty chemical products. Its solutions are used to bond, seal, protect and assemble materials in commercial and industrial applications, including packaging, hygiene products, construction, transportation, electronics and durable goods.
The company offers products such as hot-melt, water-based and reactive adhesives, construction adhesives, sealants, coatings and specialty formulations. H.B. Fuller serves manufacturers, contractors and other commercial customers that require bonding and sealing solutions for products, components and building materials.
Founded in 1887 by Harvey Benjamin Fuller, the company has grown from a regional adhesive producer into an international supplier serving customers across North America, Europe, Asia-Pacific and Latin America.
See Also
- Five stocks we like better than H. B. Fuller
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
